cyclopentane has been researched along with Alloxan Diabetes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SR; Pan, HL; Samoriski, G | 1 |
| Aviram, M; Fuhrman, B; Gantman, A; Hayek, T | 1 |
| DeFeudis, FV; Drieu, K; Jean, T; Vasseur, M | 1 |
| Clark, KL; Colussi, DJ; Cox, BF; Greenland, BD; Merkel, LA; Perrone, MH; Welzel, GE | 1 |
| Bast, JP; Carmines, PK; Fallet, RW; Ikenaga, H | 1 |
| Duhault, J; Lebon, F | 1 |
| Jacob, WH; Sanders, RB | 1 |
7 other study(ies) available for cyclopentane and Alloxan Diabetes
| Article | Year |
|---|---|
Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Memantine; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Streptozocin; Time Factors | 2009 |
High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cholesterol, HDL; Cyclopentanes; Diabetes Mellitus, Experimental; Glucose; Hyperglycemia; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Scavenger Receptors, Class B; Thiosemicarbazones | 2010 |
Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
Topics: Action Potentials; Animals; Cells, Cultured; Culture Media; Cyclopentanes; Diabetes Mellitus, Experimental; Diterpenes; Female; Furans; Ginkgo biloba; Ginkgolides; Glucose; Intracellular Fluid; Islets of Langerhans; Lactones; Membrane Potentials; Mice; Mice, Inbred Strains; Microelectrodes; Plant Extracts | 1994 |
Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats.
Topics: Adenosine; Adenosine Deaminase; Adipocytes; Animals; Blood Glucose; Blood Pressure; Cyclopentanes; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Lipolysis; Male; Norepinephrine; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Triglycerides | 1997 |
Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus.
Topics: Adenosine Triphosphate; Animals; Arterioles; Benzopyrans; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glyburide; Hypoglycemic Agents; Male; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2000 |
The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
Topics: Animals; Blood Coagulation Tests; Capillaries; Capillary Permeability; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypoglycemic Agents; Male; Mesentery; Pyrroles; Rats; Skin; Sulfonylurea Compounds; Thrombosis | 1972 |
Action of epinephrine on the distribution of two model amino acids in the diabetic rat.
Topics: Amino Acids; Aminoisobutyric Acids; Animals; Carbon Isotopes; Cyclopentanes; Diabetes Mellitus, Experimental; Diaphragm; Epinephrine; Female; Heptoses; Insulin, Isophane; Liver; Models, Biological; Muscles; Myocardium; Rats; Time Factors | 1971 |